• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用分布回归模型对乳腺癌女性患者进行生存时间分析。

Survival time analysis in women with breast cancer using distributional regression models.

作者信息

Lima Isabela da Silva, Silva Sóstenes Jerônimo da, Brighenti Carla Regina Guimarães, Nakamura Luiz Ricardo, Oliveira Tiago Almeida de, Oliveira Milena Edite Casé de, Ramires Thiago Gentil

机构信息

Programa de Pós-graduação em Estatística e Experimentação Agropecuária, Universidade Federal de Lavras, Lavras, Brasil.

Programa de Pós-graduação em Biometria e Estatística Aplicada, Universidade Federal Rural de Pernambuco, Recife, Brasil.

出版信息

Cad Saude Publica. 2025 Aug 22;41(8):e00073324. doi: 10.1590/0102-311XEN073324. eCollection 2025.

DOI:10.1590/0102-311XEN073324
PMID:40862438
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12404312/
Abstract

Cancer is a global public health concern due to its high mortality rates. In Brazil, breast cancer is one of the leading causes of disease and death among women in all regions of the country, with higher mortality rates in less developed regions. Hence, this study analyzes variables associated with survival time in breast cancer patients in Campina Grande, Paraíba State, Brazil. Distributional regression models, also known as generalized additive models for location, scale, and shape (GAMLSS), were used due to their flexibility in explaining complex behaviors of a given response (for example, survival time) based on other variables. Tumor site, age, number of hormone therapy, radiotherapy and chemotherapy sessions, and molecular markers such as estrogen receptor, progesterone receptor, Ki-67 protein, p53, HER2 mutation and molecular subtype were examined. Two different GAMLSS were fitted considering Weibull and log-normal distributions, the former of which is more appropriate per the Akaike information criterion. Using a variable selection procedure specific to GAMLSS, we identified four covariates that directly affect average survival time: number of hormone therapy and chemotherapy sessions, p53 status, and estrogen receptor status. Excepting estrogen receptor status, the other covariates selected to explain average survival time were also used to explicitly explain the variability of these times.

摘要

由于癌症的高死亡率,它已成为一个全球公共卫生问题。在巴西,乳腺癌是该国所有地区女性疾病和死亡的主要原因之一,在欠发达地区死亡率更高。因此,本研究分析了巴西帕拉伊巴州大坎皮纳市乳腺癌患者生存时间的相关变量。由于分布回归模型(也称为位置、尺度和形状的广义相加模型,即GAMLSS)在基于其他变量解释给定响应(例如生存时间)的复杂行为方面具有灵活性,所以使用了该模型。研究考察了肿瘤部位、年龄、激素治疗、放疗和化疗疗程的次数,以及雌激素受体、孕激素受体、Ki-67蛋白、p53、HER2突变和分子亚型等分子标志物。考虑到威布尔分布和对数正态分布,拟合了两种不同的GAMLSS,根据赤池信息准则,前者更为合适。使用特定于GAMLSS的变量选择程序,我们确定了四个直接影响平均生存时间的协变量:激素治疗和化疗疗程的次数、p53状态和雌激素受体状态。除雌激素受体状态外,其他用于解释平均生存时间的协变量也被用来明确解释这些时间的变异性。

相似文献

1
Survival time analysis in women with breast cancer using distributional regression models.使用分布回归模型对乳腺癌女性患者进行生存时间分析。
Cad Saude Publica. 2025 Aug 22;41(8):e00073324. doi: 10.1590/0102-311XEN073324. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
4
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Sexual Harassment and Prevention Training性骚扰与预防培训
7
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
8
Bisphosphonates for breast cancer.用于乳腺癌的双膦酸盐类药物。
Cochrane Database Syst Rev. 2005 Jul 20(3):CD003474. doi: 10.1002/14651858.CD003474.pub2.
9
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

本文引用的文献

1
Different prognosis of left compared to right breast cancer: A systematic review and meta-analysis.左乳与右乳乳腺癌预后不同:系统评价和荟萃分析。
Cancer Epidemiol. 2024 Aug;91:102581. doi: 10.1016/j.canep.2024.102581. Epub 2024 May 15.
2
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
3
Breast cancer: age incidence, hormone receptor status and family history in Najaf, Iraq.
伊拉克纳杰夫的乳腺癌:年龄发病率、激素受体状态和家族史。
J Med Life. 2022 Oct;15(10):1318-1321. doi: 10.25122/jml-2022-0296.
4
Cox model and decision trees: an application to breast cancer data.Cox模型与决策树:在乳腺癌数据中的应用
Rev Panam Salud Publica. 2022 Mar 23;46:e17. doi: 10.26633/RPSP.2022.17. eCollection 2022.
5
Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India.他莫昔芬、芳香化酶抑制剂及转换疗法(辅助内分泌治疗)对印度激素受体阳性绝经后乳腺癌女性的成本效益分析
Breast Cancer (Dove Med Press). 2021 Nov 27;13:625-640. doi: 10.2147/BCTT.S331831. eCollection 2021.
6
Comparison between Highly Complex Location Models and GAMLSS.高度复杂位置模型与广义加性模型和位置尺度模型的比较。
Entropy (Basel). 2021 Apr 16;23(4):469. doi: 10.3390/e23040469.
7
Serum interleukin-6 in schizophrenia: A system review and meta-analysis.精神分裂症患者血清白细胞介素-6:一项系统评价与荟萃分析。
Cytokine. 2021 May;141:155441. doi: 10.1016/j.cyto.2021.155441. Epub 2021 Jan 30.
8
Assessment of the Gail Model in Estimating the Risk of Breast Cancer: Effect of Cancer Worry and Risk in Healthy Women.评估盖尔模型在估计乳腺癌风险中的作用:癌症担忧和健康女性风险的影响
Asian Pac J Cancer Prev. 2019 Jun 1;20(6):1765-1771. doi: 10.31557/APJCP.2019.20.6.1765.
9
Epidemiological characteristics of and risk factors for breast cancer in the world.全球乳腺癌的流行病学特征及危险因素
Breast Cancer (Dove Med Press). 2019 Apr 10;11:151-164. doi: 10.2147/BCTT.S176070. eCollection 2019.
10
Breast Cancer Treatment: A Review.乳腺癌治疗:综述。
JAMA. 2019 Jan 22;321(3):288-300. doi: 10.1001/jama.2018.19323.